Immunome IMNM Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Immunome’s reported figures.
The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunome's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunome's free cash flow?
- Immunome (IMNM) reported free cash flow of -$61.64M in Q1 2026.
- How has Immunome's free cash flow changed year-over-year?
- Immunome's free cash flow decreased by 8.7% year-over-year, from -$56.72M to -$61.64M.
- What is the long-term trend for Immunome's free cash flow?
- Over 3 years (2021 to 2025), Immunome's free cash flow has grown at a 122.1% compound annual growth rate (CAGR), from -$18.31M to -$200.6M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.